10,028
Views
4
CrossRef citations to date
0
Altmetric
Review

Meniere disease subtyping: the direction of diagnosis and treatment in the future

, , , , &
Pages 115-127 | Received 21 Oct 2021, Accepted 13 Jan 2022, Published online: 22 Feb 2022

References

  • Lopez-Escamez JA, Carey J, Chung WH, et al. Diagnostic criteria for Menière’s disease. J Vestib Res Equilib Orientat. 2015;25:1–7.
  • Hallpike CS, Cairns H. Observations on the pathology of Ménière’s syndrome: (section of otology). Proc R Soc Med. 1938;31:1317–1336.
  • Hülse R, Biesdorf A, Hörmann K, et al. Peripheral vestibular disorders: an epidemiologic survey in 70 million individuals. Otol Neurotol. 2019;40:88–95.
  • Harris JP, Alexander TH. Current-day prevalence of Ménière’s syndrome. Audiol Neurotol. 2010;15:318–322.
  • Shojaku H, Watanabe Y, Fujisaka M, et al. Epidemiologic characteristics of definite Ménière’s disease in Japan. ORL; J Oto-Rhino-Laryngol Relat Specialties. 2005;67:305–309.
  • Brandt T, DIeterich M. The dizzy patient: don’t forget disorders of the central vestibular system. Nat Rev Neurol. 2017;13:352–362.
  • Pyykkö I, Nakashima T, Yoshida T, et al. Ménière’s disease: a reappraisal supported by a variable latency of symptoms and the MRI visualisation of endolymphatic hydrops. BMJ Open. 2013;3:e001555.
  • Kim SY, Lee CH, Min C, et al. Bidirectional analysis of the association between Ménière’s disease and depression: two longitudinal follow‐up studies using a national sample cohort. Clin Otolaryngol. 2020;45:687–694.
  • Pearson BW, Brackmann DE. Committee on hearing and equilibrium guidelines for reporting treatment results in Meniere’s disease. Otolaryngol Neck Surg. 1985;93:579–581.
  • Surgery N, Monsell M, Balkany TA, et al. Committee on hearing and equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere’s disease. Otolaryngol Neck Surg. 1995;113:181–185.
  • Editorial Board of Chinese Journal of Otorhinolaryngology Head and Neck Surgery, Society of Otorhinolaryngology Head and Neck Surgery Chinese Medical Association. Guideline of diagnosis and treatment of Meniere disease (2017). Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017;52(3):167–172.
  • Tyrrell JS, Whinney DJD, Ukoumunne OC, et al. Prevalence, associated factors, and comorbid conditions for Ménière’s disease. Ear Hear. 2014;35:e162–e169.
  • Greco A, Gallo A, Fusconi M, et al. Meniere’s disease might be an autoimmune condition?. Autoimmun Rev. 2012;11:731–738.
  • Derebery MJ. Allergic and immunologic features of Ménière’s disease. Otolaryngol Clin North Am. 2011;44:655–666.
  • Lopez-Escamez JA, Dlugaiczyk J, Jacobs J, et al. Accompanying symptoms overlap during attacks in Meniere’s disease and vestibular migraine. Front Neurol. 2014;5:265.
  • Radtke A, Lempert T, Gresty MA, et al. Migraine and Meniere’s disease: is there a link?. Neurology. 2002;59:1700–1704.
  • Von Brevern M, Neuhauser H. Epidemiological evidence for a link between vertigo and migraine. J Vestib Res. 2011;21:299–304. cited 2020 Dec 11.
  • Ohmen JD, White CH, Li X, et al. Genetic evidence for an ethnic diversity in the susceptibility to Ménière’s disease. Otol Neurotol. 2013;34:1336–1341.
  • Requena T, Espinosa‐Sanchez JM, Cabrera S, et al. Familial clustering and genetic heterogeneity in Meniere’s disease. Clin Genet. 2014;85:245–252.
  • Lee JM, Kim MJ, Jung J, et al. Genetic aspects and clinical characteristics of familial meniere’s disease in a South Korean population. Laryngoscope. 2015;125:2175–2180.
  • Requena T, Cabrera S, Martin-Sierra C, et al. Identification of two novel mutations in FAM136A and DTNA genes in autosomal-dominant familial Meniere’s disease. Hum Mol Genet. 2015;24:1119–1126.
  • Martín-Sierra C, Gallego-Martinez A, Requena T, et al. Variable expressivity and genetic heterogeneity involving DPT and SEMA3D genes in autosomal dominant familial Meniere’s disease. Eur J Hum Genet. 2017;25:200–207.
  • Oh EH, Shin J-H, Kim H-S, et al. Rare variants of putative candidate genes associated with sporadic Meniere’s disease in East Asian population. Front Neurol. 2020;10:1424.
  • Roman-Naranjo P, Gallego-Martinez A, Soto-Varela A, et al. Burden of rare variants in the OTOG gene in familial Meniere’s disease. Ear Hear. 2020;41:1598–1605.
  • Roman-Naranjo P, Moleon MDC, Aran I, et al. Rare coding variants involving MYO7A and other genes encoding stereocilia link proteins in familial meniere disease. Hear Res. 2021;409:108329.
  • Williams LL, Lowery HW, Shannon BT. Evidence of persistent viral infection in Meniere’s disease. Arch Otolaryngol - Head Neck Surg. 1987;113:397–400.
  • Cotter CS, Singleton GT, Corman LC. Immune-mediated inner ear disease and Parvovirus B19. Laryngoscope. 1994;104:1235–1239.
  • Gacek RR. Ménière’s disease is a viral neuropathy. ORL J Otorhinolaryngol Relat Spec. 2009;71(2):78–86.
  • Dean NJ, Pastras C, Brown D, et al. Are viral-infections associated with Ménière’s disease? A systematic review and meta-analysis of molecular-markers of viral-infection in case-controlled observational studies of MD. PLoS One. 2019;14:e0225650.
  • Dornhoffer JL, Kaufman Arenberg I. Immune mechanisms in Meniere’s syndrome. Otolaryngol Clin North Am. 1997;30:1017–1026.
  • Gloddek B, Arnold W. Clinical and Experimental Studies of Autoimmune Inner Ear Disease. Acta Otolaryngol. 2002;122:10–14.
  • Teggi R, Battista RA, Di Berardino F, et al. Evaluation of a large cohort of adult patients with ménière’s disease: bedside and clinical history. Acta Otorhinolaryngol Ital. 2020;40:444–449.
  • Kim SY, Song YS, Wee JH, et al. Association between Ménière’s disease and thyroid diseases: a nested case–control study. Sci Rep. 2020;10:18224.
  • Duke WW. Meniere’s syndrome caused by allergy. AMA. 1923;81:20–22.
  • Powers WH. Allergic factors in Meniere’s disease. Trans Am Acad Ophthalmol Otolaryngol. 1973;77:ORL22–9.
  • Derebery MJ. Allergic management of Meniere’s disease: an outcome study. Otolaryngol Neck Surg. 2000;122:174–182.
  • Foster CA, Breeze RE. The Meniere attack: an ischemia/reperfusion disorder of inner ear sensory tissues. Med Hypotheses. 2013;81:1108–1115. [Internet].
  • Yazawa Y, Kitano H, Suzuki M, et al. Studies of cochlear blood flow in Guinea pigs with endolymphatic hydrops. Orl. 1998;60:4–11.
  • Lundquist PG, Kimura R, Wersaell J. Experiments in endolymph circulation. Acta Otolaryngol Suppl. 1964;188(SUPPL 188):198+.
  • Baloh RW. Harold schuknecht and pathology of the ear. Otol Neurotol. 2001;22:113–122.
  • Fiorino F, Pizzini FB, Beltramello A, et al. Reliability of magnetic resonance imaging performed after intratympanic administration of gadolinium in the identification of endolymphatic hydrops in patients with Ménière’s disease. Otol Neurotol. 2011;32:472–477.
  • Nakashima T, Naganawa S, Teranishi M, et al. Endolymphatic hydrops revealed by intravenous gadolinium injection in patients with Ménière’s disease. Acta oto-laryngologica. 2010;130(3):338–343.
  • Yazawa Y, Kitahara M. Bilateral endolymphatic hydrops in Meniere’s disease: review of temporal bone autopsies. Ann Otol Rhinol Laryngol. 1990;99:524–528.
  • Wu H. Endolymphatic hydrops detected by 3-dimensional fluid-attenuated inversion recovery MRI following intratympanic injection of gadolinium in the asymptomatic contralateral ears of patients with unilateral Ménière’s disease. Med Sci Monit. 2015;21:701–707.
  • Clemis JD, Valvassori GE. Recent radiographic and clinical observations on the vestibular aqueduct: (A preliminary report). Otolaryngol Clin North Am. 1968;1:339–352.
  • Mainnemarre J, Hautefort C, Toupet M, et al. The vestibular aqueduct ossification on temporal bone CT: an old sign revisited to rule out the presence of endolymphatic hydrops in Menière’s disease patients. Eur Radiol. 2020;30:6331–6338.
  • Friberg U, Stahle J, Svedberg A. The natural course of Meniere’s disease. Acta Otolaryngol. 1983;96:72–77.
  • Gürkov R, Jerin C, Flatz W, et al. Clinical manifestations of hydropic ear disease (Menière’s). Eur Arch Otorhinolaryngol. 2019;276:27–40.
  • Rauch SD. Clinical hints and precipitating factors in patients suffering from Meniere’s disease. Otolaryngol Clin North Am. 2010;43:1011–1017.
  • Kitahara M. Bilateral aspects of Meniere’s disease: meniere’s disease with bilateral fluctuant hearing loss. Acta Otolaryngol. 1991;111:74–77.
  • Tumarkin A. the otolithic catastrophe: a new syndrome. BMJ. 1936;2:175–177.
  • Wu Q, Li X, Sha Y, et al. Clinical features and management of Meniere’s disease patients with drop attacks. Eur Arch Oto-Rhino-Laryngology. 2019;276:665–672.
  • Shen KC, Young YH. Lermoyez syndrome revisited: 100-year mystery. Acta Otolaryngol. 2018;138:981–986.
  • Schmidt PH, Schoonhoven R. Lermoyez’s syndrome a follow-up study in 12 patients. Acta Otolaryngol. 1989;107:467–473.
  • Espinosa-Sanchez JM, Lopez-Escamez JA. Menière’s disease. Handb Clin Neurol. 2016;137:257-77. doi: https://doi.org/10.1016/B978-0-444-63437-5.00019-4.
  • Ballester M, Liard P, Vibert D, et al. Meniere’s Disease in the Elderly. Otol Neurotol. 2002;23:73–78.
  • Hausler R, Toupet M, Guidetti G, et al. Ménière’s disease in children. Am J Otolaryngol. 1987;8:187–193.
  • Wang C, Wu C, Cheng P, et al. Pediatric Meniere’s disease. Int J Pediatr Otorhinolaryngol. 2018;105:16–19.
  • Espinosa-Sanchez JM, Lopez-Escamez JA. The pharmacological management of vertigo in Meniere disease. Expert Opin Pharmacother. 2020;21:1753–1763.
  • Nevoux J, Barbara M, Dornhoffer J, et al. International consensus (ICON) on treatment of Ménière’s disease. Eur Ann Otorhinolaryngol Head Neck Dis [Internet]. 2018;135:S29–S32.
  • Gbahou F, Davenas E, Morisset S, et al. Effects of betahistine at histamine H 3 receptors: mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo. J Pharmacol Exp Ther. 2010;334:945–954.
  • Murdin L, Hussain K, and Schilder AGM. Betahistine for symptoms of vertigo. Cochrane Database Syst Rev. 2016;(6): CD010696.
  • Adrion C, Fischer CS, Wagner J, et al. Efficacy and safety of betahistine treatment in patients with Meniere’s disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ. 2016:h6816. DOI:https://doi.org/10.1136/bmj.h6816.
  • Crowson MG, Patki A, Tucci DL. A systematic review of diuretics in the medical management of Ménière’s disease. Otolaryngol Neck Surg. 2016;154:824–834.
  • Ralli G, Celestino D, Fabbricatore M, et al. Effect of Acetazolamide on Menière’s disease. Acta Otorhinolaryngol Ital. 1989;9(5):503–509.
  • Brookes GB, Booth JB. Oral Acetazolamide in Menière’s disease. J Laryngol Otol. 1984;98:1087–1095.
  • Rarey KE, Curtis LM. Receptors for glucocorticoids in the human inner ear. Otolaryngol Head Neck Surg. 1996;115:38–41.
  • Garduño-Anaya MA, De Toledo HC, Hinojosa-González R, et al. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière’s disease: a two-year prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol Neck Surg. 2005;133:285–294.
  • Silverstein H, Isaacson JE, Olds MJ, et al. Dexamethasone inner ear perfusion for the treatment of Meniere’s disease: a prospective, randomized, double-blind, crossover trial. Am J Otol. 1998;19:196–201.
  • Paragache G, Panda NK, Ragunathan M, et al. Intratympanic dexamethasone application in Meniere’s disease - Is it superior to conventional therapy?. Indian J Otolaryngol Head Neck Surg. 2005;57:21–23.
  • Lambert PR, Nguyen S, Maxwell KS, et al. A randomized, double-blind, placebo-controlled clinical study to assess safety and clinical activity of OTO-104 given as a single intratympanic injection in patients with unilateral ménière’s disease. Otol Neurotol. 2012;33:1257–1265.
  • Lavigne P, Lavigne F, Saliba I. Intratympanic corticosteroids injections: a systematic review of literature. Eur Arch Oto-Rhino-Laryngology. 2016;273:2271–2278.
  • Horii A, Kitahara T, Uno A, et al. Vestibular function and vasopressin. Acta Otolaryngol Suppl. 2004;124:50–53.
  • Kitahara T, Horii A, Imai T, et al. Does endolymphatic sac decompression surgery prevent bilateral development of unilateral Ménière disease?. Laryngoscope. 2014;124:1932–1936.
  • Thomsen J, Per Bonding BB. The Non-specific effect of endolymphatic sac surgery in treatment of Meniere’s disease: a prospective, randomized controlled study comparing “classic” endolymphatic sac surgery with the insertion of a ventilating tube in the tympanic membrane. Acta Otolaryngol. 1998;118:769–773.
  • Chung JW, Fayad J, Linthicum F, et al. Histopathology after endolymphatic sac surgery for Meniere’s syndrome. Otol Neurotol. 2011;32:1–7.
  • Committee on Hearing and Equilibrium. Report of Subcommittee on Equilibrium and its Measurement. Meniere’s disease: criteria for diagnosis and evaluation of therapy for reporting. Trans - Am Acad Ophthalmol Otolaryngol. 1972;76:1462–1464.
  • Kato M, Sugiura M, Shimono M, et al. Endolymphatic hydrops revealed by magnetic resonance imaging in patients with atypical Meniere’s disease. Acta Otolaryngol. 2013;133:123–129.
  • Iwasaki S, Shojaku H, Murofushi T, et al. Diagnostic and therapeutic strategies for Meniere’s disease of the Japan Society for Equilibrium Research. Auris Nasus Larynx. 2021;48:15–22.
  • Gürkov R, Hornibrook J. On the classification of hydropic ear disease (Menière’s disease). HNO. 2018;66:455–463.
  • Chaves AG, Boari L, Munhoz MSL. The outcome of patients with ménière’s disease. Braz J Otorhinolaryngol. 2007;73:346–350.
  • Clemmens C, Ruckenstein M. Characteristics of patients with unilateral and Bilateral Ménière’s Disease. Otol Neurotol. 2012;33:1266–1269.
  • Orchik DJ, Shea JJ Jr, and Ge NN. Summating potential and action potential ratio in Meniere’s disease before and after treatment. Am J Otol. 1998;19(4):478–482.
  • Havia M, Kentala E. Progression of symptoms of dizziness in Ménière’s Disease. Arch Otolaryngol Neck Surg. 2004;130:431.
  • Stahle J, Friberg U, Svedberg A. Long-term Progression of Meniere’s Disease. Acta Otolaryngol. 1991;111:78–83.
  • Belinchon A, Perez- Garrigues H, Tenias JM, et al. Hearing assessment in Menière’s disease. Laryngoscope. 2011;121:622–626.
  • Wang Y, Diao T, Han L, et al. Association of Meniere’s disease and retinal vascular calibre: a prospective observational study in China. BMJ Open. 2018;8:e022069.
  • Cha YH, Brodsky J, Ishiyama G, et al. The relevance of migraine in patients with Ménière’s disease. Acta Otolaryngol. 2007;127:1241–1245.
  • Unlu M, Sevim DG, Gultekin M, et al. Changes in retinal vessel diameters in migraine patients during attack-free period. Int J Ophthalmol. 2017;10:439–444.
  • Sarna B, Abouzari M, Lin HW, et al. A hypothetical proposal for association between migraine and Meniere’s disease. Med Hypotheses. 2020;134:1–5.
  • Ghavami Y, Haidar YM, Moshtaghi O, et al. Evaluating quality of life in patients with Meniere’s disease treated as migraine. Ann Otol Rhinol Laryngol. 2018;127:877–887.
  • Abouzari M, Abiri A, Djalilian HR, et al. Successful treatment of a child with definite Meniere’s disease with the migraine regimen. Am J Otolaryngol. 2019;40:440–442.
  • Rego ÂR, Dias D, Pinto A, et al. The cardiovascular aspects of a Ménière’s disease population - A pilot study. J Otol. 2019;14:51–56.
  • Montes-Jovellar L, Guillen-Grima F, Perez-Fernandez N. Cluster analysis of auditory and vestibular test results in definite menière’s disease. Laryngoscope. 2011;121:1810–1817.
  • Teggi R, Meli A, Trimarchi M, et al. Does Ménière’s disease in the elderly present some peculiar features?. J Aging Res. 2012;2012:1–5.
  • Frejo L, Soto-Varela A, Santos-Perez S, et al. Clinical subgroups in bilateral Meniere disease. Front Neurol. 2016;7:1–10.
  • Frejo L, Martin-Sanz E, Teggi R, et al. Extended phenotype and clinical subgroups in unilateral Meniere disease: a cross-sectional study with cluster analysis. Clin Otolaryngol. 2017;42:1172–1180.
  • Espinosa-Sanchez JM, Lopez-Escamez JA. New insights into pathophysiology of vestibular migraine. Front Neurol. 2015;6:10–15.
  • Vergara-Jimenez M, Missimer A, DiMarco DM, et al. Higher prevalence of autoimmune diseases and longer spells of vertigo in patients affected with familial Ménière’s disease: a clinical comparison of familial and sporadic Ménière’s disease. EC Nutr. 2014;1:164–173.
  • Crossley J, Hussaini AS, Kim HJ, et al. Ménière’s disease clinical subtypes in a population from the USA. J Laryngol Otol. 2020;134:24–28.
  • Kim H-J, Lee H-J, An S-Y, et al. Analysis of the prevalence and associated risk factors of tinnitus in adults. Chen L, editor. PLoS One. 2015;10:e0127578.
  • Bruderer SG, Bodmer D, Stohler NA, et al. Population-based study on the epidemiology of Ménière’s disease. Audiol Neurotol. 2017;22:74–82.
  • Lee HJ, Lee JM, Shim DB, et al. Is early progression to bilateral involvement in Menière’s disease a poor prognostic indicator?. Otol Neurotol. 2019;40:1333–1338.
  • Enander A, Stahle J. Hearing in Menière’s disease: a study of pure-tone audiograms in 334 patients. Acta Otolaryngol. 1967;64:543–556.
  • Frejo L, Gallego-Martinez A, Requena T, et al. Proinflammatory cytokines and response to molds in mononuclear cells of patients with Meniere disease. Sci Rep. 2018;8:5974.
  • Moleon MDC, Martinez-Gomez E, Flook M, et al. Clinical and cytokine profile in patients with early and late onset meniere disease. J Clin Med. 2021;10:4052.
  • Flook M, Escalera-Balsera A, Gallego-Martinez A, et al. Dna methylation signature in mononuclear cells and proinflammatory cytokines may define molecular subtypes in sporadic meniere disease. Biomedicines. 2021;9:1530.
  • Frejo L, Giegling I, Teggi R, et al. Genetics of vestibular disorders: pathophysiological insights. J Neurol. 2016;263:45–53.
  • Gallego-Martinez A, Lopez-Escamez JA. Genetic architecture of Meniere’s disease. Hear Res. 2020;397:107872.
  • Martín-Sierra C, Requena T, Frejo L, et al. A novel missense variant in PRKCB segregates low-frequency hearing loss in an autosomal dominant family with Meniere’s disease. Hum Mol Genet. 2016;25:3407–3415.
  • Mehrjoo Z, Kahrizi K, Mohseni M, et al. Limbic system associated membrane protein mutation in an Iranian family diagnosed with ménière’s disease. Arch Iran Med. 2020;23:319–325.
  • Teggi R, Zagato L, Delli Carpini S, et al. Genetics of ion homeostasis in Ménière’s Disease. Eur Arch Oto-Rhino-Laryngology. 2017;274:757–763.
  • Eckhard A, Gleiser C, Arnold H, et al. Water channel proteins in the inner ear and their link to hearing impairment and deafness. Mol Aspects Med. 2012;33:612–637.
  • Eckhard AH, Zhu M, O’Malley JT, et al. Inner ear pathologies impair sodium-regulated ion transport in Meniere’s disease. Acta Neuropathol. 2019;137:343–357.
  • Bächinger D, Luu N, Kempfle JS, et al. Vestibular aqueduct morphology correlates with endolymphatic sac pathologies in Menière’s disease—A correlative histology and computed tomography study. Otol Neurotol. 2019;40:e548–e555.
  • Bächinger D, Brühlmann C, Honegger T, et al. Endotype-phenotype patterns in Meniere’s disease based on gadolinium-enhanced MRI of the vestibular aqueduct. Front Neurol. 2019;10:1–11.
  • Smitherman TA, Burch R, Sheikh H, et al. The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache J Head Face Pain. 2013;53:427–436.
  • House JW, Doherty JK, Fisher LM, et al. Meniere’s disease: prevalence of contralateral ear involvement. Otol Neurotol. 2006;27:355–361.
  • Di Berardino F, Cesarani A. Gluten sensitivity in Meniere’s disease. Laryngoscope. 2012;122:700–702.
  • Sen P, Georgalas C, Papesch M. Co-morbidity of migraine and Ménière’s disease – is allergy the link?. J Laryngol Otol. 2005;119:455–460.
  • Derebery MJ, Berliner KI. Prevalence of allergy in Meniere’s disease. Otolaryngol Neck Surg. 2000;123:69–75.
  • Kim SK, Kim JH, Jeon SS, et al. Relationship between sleep quality and dizziness. Veauthier C, editor. PLoS One. 2018;13:e0192705.